Summary. The modal DNA values of 1465 tumours, together with other factors of possible prognostic importance, were related to the survival of the patients, using regression models (Kay, 1977) . For most tumour sites except the testis, the distributions of modal DNA values were bimodal, with peaks at the diploid level and in the triploid-tetraploid range. For all tumour sites except the cervix uteri, patients in the low (near-diploid) range showed better survival; the reverse was true for squamouscell carcinoma of the cervix uteri. Other variables showed the following effects: for all sites except the testis, younger patients showed a better survival; for the cervix and corpus uteri, breast and ovary, increasing clinical stage was associated with poorer survival. Where evaluated, histological grade appeared to be associated with survival rate, the less well differentiated tumours having a worse prognosis, except for the breast, where the reverse correlation was noted. For carcinoma of the bladder, females had a poorer survival rate than males.
MEASUREMENTS of nuclear DNA content have been widely used to estimate the approximate modal chromosome numbers of human tumours. It has previously been shown that the modal DNA values of tumours at most sites tend to fall into 2 groups: a near-diploid and a "high-ploidy" group (the latter centred in the triploid or hypotetraploid region), suggesting that polyploidization has occurred in a proportion of the tumours. It has further been shown that the overall prognosis of the 2 groups differs for some tumour sites or types (Atkin, 1971 (Atkin, , 1972 (Atkin, , 1976a Atkin & Richards, 1962) .
In the present paper, a new analysis is presented based on survival-data regression models. This method allows the inclusion of more cases, not being restricted to those followed up for arbitrary periods, such as 5 years, and thus utilizes more information.
MATERIALS AND METHODS
The distribution of the 1465 tumours according to site and histological type is shown in Table I . DNA measurements were made on Feulgen-stained smears (prepared from fresh tumour material obtained before the start of treatment) using an integrating microdensitometer as previously described (Atkin et al., 1966; Atkin & Richards, 1956 ). Amount of DNA was assessed in arbitrary units (110=diploid level; 220=tetraploid level). Usually the primary tumour was studied, but a proportion of the specimens at some sites were of metastatic tumour (see Table I ).
Wherever possible, the following informa- Cox (1972) while the Weibull form used here has been used by Prentice (1973) and Williams (1978) , amongst others. This particular parametric form was initially chosen because the data sets at several sites w%rere quite small and, as pointed out by Williams (1978) , it is not clear that efficiency losses in using the non-parametric form (Cox, 1972) are negligible in such small samples. In addition, checks using residuals from the fitted models as discussed in Kay (1977) (Atkin, 1973) . The precise form of the curve tends to vary from site to site. Thus, ovarian and bladder carcinomas are relatively more often hypodiploid and less often hyperdiploid than tumours at the other sites. Similarly, the DNA level of the second ("high-ploidy") peak varies, being relatively low (in the triploid rather than hypotetraploid region) for ovarian and large bowel carcinomas.
Analysis of survival data
It is clear from the survival curves in Fig. 2 that between-site differences exist in the general shape of the curves, and for (Fig. 2a ).
-~~~~~~~~~~~Cervix Uteri a) SCC:
.~~~~~~~~b) Adenocarcinoma: For all sites except the cervix uteri, patients in the low-DNA groups (DNA<, 165) had the better survival. Not all the coefficients associated with distances away from the diploid and tetraploid DNA values approached significance, although their values suggest that within the cervix uteri, large bowel, bladder and reticuloses sites near-diploid and near-tetraploid DNA values are associated with poorer survival, whilst in the corpus uteri, breast, ovary and testis sites greater distance from these values is associated with shorter survival times.
The effects of the remaining independent variables may be summarized as follows: Increasing survival proportions associated with histological gradings-3-2->l (Cervix uteri, bladder) 3-*1---+2 (Corpus uteri) 2-*3-->1 (Ovary) 1-*2-+3 (Breast) large bowel,
The differences between Grades 1 and 2 in the corpus uteri site and 2 and 3 in the ovary site are very small. The reanalysis of the breast data confirmed the above conclusions relating to breast site. The coefficients of the dummy variables, however, indicate that patients with no information on either stage, grade or lymphnodes with/without metastases have significantly worse survival.
The further analysis of the cervix uteri data to include duration of symptoms indicated that this factor is not of prog- Significance (P) *< 0-1, ** < 0-05, **< 0)[, **** < 0(fl).
nostic importance, the estimated coefficient of -001 having a standard error of 001.
DISCUSSION
Although the complete cytogenetic study of a human tumour requires the detailed and painstaking analysis of its chromosome changes, significant information relating to these changes can readily be obtained from DNA measurements on interphase cells. Moreover, data can easily be obtained with this technique on unselected series of cases, including those in which mitoses are absent from the sample of cells obtained for study. The present results have only established tenuous associations between DNA measurement and prognosis at sites where the tumours can be placed in one or other of 2 "ploidy groups".
Correlations between DNA value and prognosis have been investigated by Tavares et al. (1966) , who found a relatively poor prognosis for carcinomas of the bladder and prostate when the DNA value was near-triploid or near-hexaploid. The data presented here show that different sites differ both with respect to the form of the distribution curve of DNA values of randomly selected series of tumours and to the relationship between the ploidy group of individual tumours from a given site and their prognosis. A priori suggestions that tumours with modal values at or close to the diploid, and perhaps also to the tetraploid level, have a different prognosis from those within that ploidy group but departing substantially from these levels were not supported conclusively. Nevertheless individual trends, some of which approached significance, suggested that tumours close to these euploid levels have a slightly worse prognosis for the cervix uteri, large bowel, bladder and reticuloses, and a slightly better prognosis for the corpus uteri, breast, ovary and testis.
Chromosome analysis using banding techniques is of course a more discriminating as well as a more difficult technique than Feulgen cytophotometry. Whether it wvill prove more useful as a diagnostic or prognostic guide, for example by enabling a distinction to be made between neardiploid tumours with slight chromosome changes such as one or 2 trisomies or translocations and those with more extensive changes remains to be seen. 
